Between Day 21 of Cycle 1 and Day 1 of Cycle 2 and then every 3-4 months after that, participant will have a bone marrow biopsy/aspirate to check the status of the disease and for cytogenetic testing. Biomarker testing on the bone marrow aspirate sample will be performed each time an aspirate is performed.